MENU
NOV 09, 2017 12:00 PM PST

On the road to realizing tissue engineering's transformative potential: multidisciplinary approach to accelerate bench-to-clinic transition

Speakers
  • CEO and Co-Founder, EpiBone
    Biography
      Nina Tandon is CEO and co-founder of EpiBone, the world's first company growing living human bones for skeletal reconstruction. She is the co-author of Super Cells: Building with Biology, a book that explores the new frontier of biotech. She is a TED Senior Fellow, Adjunct Professor of Electrical Engineering at the Cooper Union and a former Staff Associate Postdoctoral Researcher in the Laboratory for Stem Cells and Tissue Engineering, Columbia University. She has a Bachelor's in Electrical Engineering from the Cooper Union, a Master's in Bioelectrical Engineering from MIT, a PhD in Biomedical Engineering, and an MBA from Columbia University. Her PhD research focused on studying electrical signaling in the context of tissue engineering, and has worked with cardiac, skin, bone, and neural tissue.
    • Director of Therapeutics, Organovo
      Biography
        Dr. Shepherd has more than 17 years of experience in Tissue Engineering and Regenerative Medicine research. Dr. Shepherd's research in vascular biology and microvascular tissue engineering has been focused on the ability to use creative approaches to generate microvascular networks to support the fabrication and surgical implantation of prevascularized neotissues. In addition to these research interests, he has successfully led early-stage research programs in liver biology, oncology and directed differentiation of stem cells within 3D and bioprinted tissues. Prior to joining Organovo, he was an Associate Research Scientist at the Yale School of Medicine, where he also conducted postdoctoral training. In addition to his appointment at Yale, he was a staff perfusionist at the University of Connecticut Health Center. Dr. Shepherd is a board certified clinical perfusionist (C.C.P.), received his Ph.D. in Physiological Sciences from the University of Arizona and a B.S. in Zoology from the University of Washington.

      Abstract

      A panel of experts will discuss recent advances and current challenges for the successful development and application of human tissue for drug screening, tissue replacement and eventually organ replacement.


      Show Resources
      NOV 09, 2017 12:00 PM PST

      On the road to realizing tissue engineering's transformative potential: multidisciplinary approach to accelerate bench-to-clinic transition


      Specialty

      Biotechnology

      Cell Biology

      Molecular Biology

      Cell Culture

      Cancer Research

      Biomarkers

      Genetics

      Molecular Diagnostics

      Cancer Diagnostics

      Clinical Diagnostics

      Biochemistry

      Clinical Research

      Immunology

      Stem Cell Technologies

      Dna

      Geography

      North America46%

      Europe22%

      Asia13%

      South America9%

      Africa9%

      Registration Source

      Website Visitors100%

      Job Title

      Student25%

      Research Scientist13%

      Scientist11%

      Post Doc10%

      Educator/Faculty8%

      Facility/Department Manager7%

      Medical Doctor/Specialist6%

      Biologist5%

      Executive5%

      Medical Laboratory Technician3%

      Lab Management3%

      Clinical Laboratory Scientist2%

      Consultant2%

      Marketing/Sales2%

      Organization

      Academic Institution12%

      Research Institute8%

      Hospital5%

      Clinical Laboratory4%

      Government4%

      Biotech Company2%

      Life Science Company2%

      Consultant2%

      Medical School2%

      Ambulatory Care2%

      Medical Device Company2%

      Non-Profit Organization2%

      Manufacturer & Biotech/pharma2%

      Media1%

      Other4%


      Show Resources
      Show Resources
      Attendees
      • See more